NSPR INSPIREMD INC

InspireMD to Announce Third Quarter 2025 Financial Results

InspireMD to Announce Third Quarter 2025 Financial Results

MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for domestic callers or 1-785-424-1789 for international callers. The live webinar may be accessed by visiting InspireMD’s website or by registering below. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on InspireMD’s website.

Webcast: /starthere.jsp?ei=1738063&tp_key=c84683c4fd

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR.

We routinely post information that may be important to investors on our website. For more information, please visit .

Investor Contact:

Webb Campbell

Gilmartin Group LLC





EN
21/10/2025

Underlying

NSPRINSPIREMD INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on INSPIREMD INC

 PRESS RELEASE
Free
NSPR INSPIREMD INC

InspireMD Reports Third Quarter 2025 Financial Results

InspireMD Reports Third Quarter 2025 Financial Results Successful initial CGuard Prime U.S. commercial launch drives record quarterly revenue MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the third quarter and nine months ended September 30, 2025. Recent Business Highlights: Initiated U.S. commercial launch of the CGuard Prime carotid stent systemCompleted over 100 U.S. carotid procedures across ...

November 4, 2025 1 EN
 PRESS RELEASE
Free
NSPR INSPIREMD INC

InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer

InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Peter A. Soukas, M.D., as Chief Medical Officer to advance its mission to deliver best-in-class tools for carotid intervention. “We are thrilled to have Dr. Soukas join InspireMD to help lead our clinical and medical organization with strategy and oversight at this pivotal time for the Company,” said Marvin ...

November 3, 2025 1 EN
 PRESS RELEASE
Free
NSPR INSPIREMD INC

InspireMD to Announce Third Quarter 2025 Financial Results

InspireMD to Announce Third Quarter 2025 Financial Results MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for domestic c...

October 21, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
ABG ASBURY AUTOMOTI...
SNV Synovus Financi... ... (+17)

InsiderInsights.com Daily Ratings Report: August 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ABG ASBURY AUTOMOTIVE GROUP INC
SNV SYNOVUS FINANCIAL CORP.
PSX PHILLIPS 66
FBIZ FIRST BUSINESS FINANCIAL SERVICES
BUSE FIRST BUSEY CORPORATION
ALGN ALIGN TECHNOLOGY INC.
UPS UNITED PARCEL SERVICE INC. CLASS B
PLBC PLUMAS BANCORP
TROX TRONOX HOLDINGS PLC
PCB PACIFIC CITY FINANCIAL CORP
NSPR INSPIREMD INC
JMSB JOHN MARSHALL BANCORP INC
PRME PRIME MEDICINE INC
AURX NUO THERAPEUTICS
MRAI INC.
MARPAI
INC.
08/02/25 August 2, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
TLYS TILLYS
MERC Mercer Internat... ... (+28)

Monthly Insider Special Screens: August 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

TLYS TILLYS
MERC MERCER INTERNATIONAL INC.
CDXS CODEXIS
PETS PETMED EXPRESS INC.
CLRB CELLECTAR BIOSCIENCES
NHF NEXPOINT CREDIT STRATEGIES FUN
CZWI CITIZENS COMMUNITY BANCORP
LOOP LOOP INDUSTRIES
CHMG CHEMUNG FINANCIAL CORP.
FVCB FVCBANKCORP
FGBI FIRST GUARANTY BANCSHARES
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
CMTV COMMUNITY BANCORP INC. VT
DMAC DIAMEDICA THERAPEUTICS INC.
CRDF CARDIFF ONCOLOGY INC
IMRX IMMUNEERING CORP
NSPR INSPIREMD INC
BRCC BRC INC
LEXX LEXARIA BIOSCIENCE CORP
PMNT PERFECT MOMENT LTD.
DMA DESTRA MULTI ALTERNATIVE FUND
NYC NEW YORK CITY REIT
GF INC.
FGEN THE NEW GERMANY FUND
CCIF INC.
CVM FIBROGEN INC.
CARLYLE CREDIT INCOME FUND
CEL-SCI CORPORATION
08/02/25 August 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch